Keyword: Axonics Modulation Technologies
The financing comes as Axonics closes in on the end of a clinical trial that will set it up to market the device in the U.S.
Genomics, bioelectronics and artificial intelligence are clear themes among FierceMedTech's 2017 Fierce 15 companies.
Axonics Modulation Technologies raised $20.5 million in the second closing of its series C financing.
Axonics Modulation Technologies raised $14.5 million, which will bankroll a pivotal study of its neuromodulation implant for overactive bladder.